Medical Economics August 22, 2025
Patients in value-based care practices were nearly 28% more likely to receive full guideline-directed therapy.
Humana Healthcare Research has released new data showing that Medicare Advantage patients with heart failure who are treated by value-based care (VBC) physicians are significantly more likely to receive recommended therapies than those in traditional care models.
According to Humana’s Value-Based Care Issue Brief, patients in VBC arrangements were nearly 28% more likely to receive full quadruple therapy — the gold-standard, evidence-based regimen for heart failure with reduced ejection fraction (HFrEF).
Heart failure affects more than 6.7 million Americans today, a figure expected to climb as high as 11.4 million by 2050. The condition is one of the leading causes of hospitalization among older adults...
Today's Sponsors
Today's Sponsor